Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium
Catherine M. Olsen(The University of Queensland), Aleksandra Gentry‐Maharaj(UCL Australia), Harvey A. Risch(Yale University), Elisa V. Bandera(Rutgers, The State University of New Jersey), Allan Jensen(Danish Cancer Society), Jenny Chang‐Claude(German Cancer Research Center), Robert A. Vierkant(Mayo Clinic), David C. Whiteman(The University of Queensland), Estrid Høgdall(University of Copenhagen), Susanne K. Kjær(Canadian Institutes of Health Research), Marc T. Goodman(Cancer Prevention Institute of California), Patricia G. Moorman(Duke University), Simon A. Gayther(University of Southern California), Susan J. Ramus(University of Southern California), Kathryn L. Terry(Harvard University), Rachel Palmieri Weber(Duke University), Stefan Nickels(German Cancer Research Center), Sara H. Olson(Memorial Sloan Kettering Cancer Center), Daniel W. Cramer(Brigham and Women's Hospital), Joellen M. Schildkraut(Duke University), Cathrine Hoyo(North Carolina State University), Malcolm C. Pike(Cancer Prevention Institute of California), Christina M. Nagle(The University of Queensland), Argyrios Ziogas(University of Copenhagen), Anna H. Wu(University of Southern California), Herbert Yu(University of Hawaiʻi at Mānoa), Jennifer A. Doherty(Cancer Prevention Institute of California), Montserrat García‐Closas(National Cancer Institute), Hoda Anton Culver(University of California, Irvine), Usha Menon(Queen Mary University of London), Hannah Yang(Cancer Prevention Institute of California), Shan Wang‐Gohrke(Universität Ulm), Lorna Rodriguez-Rodriguez(Rutgers, The State University of New Jersey), Ellen L Goode(Mayo Clinic), Melissa C. Larson(Mayo Clinic), Galina Lurie(Cancer Prevention Institute of California), Celeste Leigh Pearce(University of Southern California), Melony King(Rutgers, The State University of New Jersey), Mary Anne Rossing(Fred Hutch Cancer Center), Allison F. Vitonis(Brigham and Women's Hospital), Rayna K. Matsuno(Cancer Prevention Institute of California), Rebecca Hein(Technical University of Munich), Kirsten B. Moysich(Roswell Park Comprehensive Cancer Center), Roberta B. Ness(The University of Texas Health Science Center at Houston), L A Brinton(National Institutes of Health), Michael E. Carney(University of Hawaiʻi at Mānoa), Jolanta Lissowska, . ., Brooke L. Fridley(Mayo Clinic)
Cited by 230
Related Papers
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
|Nature Genetics|2010|2.6k
Intraepithelial CD8 <sup>+</sup> tumor-infiltrating lymphocytes and a high CD8 <sup>+</sup> /regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
|Proceedings of the National Academy of Sciences|2005|2.4k
Assessing the Probability That a Positive Report is False: An Approach for Molecular Epidemiology Studies
|JNCI Journal of the National Cancer Institute|2004|1.8k
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k